Joeeta is a highly experienced Attorney in all aspects of IP matters having worked in both private practice and in-house at a bio-pharmaceutical SME developing treatments for neurodegenerative disorders. Over her 25 years in the Patent and Trademark profession, Joeeta has provided valuable strategic IP advice to clients to extract maximum value and monetise their IP. In contentious matters, Joeeta has successfully led multiple Oppositions and Appeals before the European Patent Office and provided support in UK, pan-European and US litigation matters.

Specialising in Life Sciences patent matters, Joeeta handles a varied range of subject-matter from biologicals, peptides, antibodies, ADCs, stem cells, genetic engineering, nucleic acid synthesis and amplifications, gene libraries, regenerative medicines, RNAi technology, immunotherapy, plant products and formulations, diagnostics, implants and medical devises.

Ranging from Multinationals companies, Public bodies (NHS), Universities, Start-Ups and SMEs, Joeeta provides the full range of patent services tailored to the client’s needs, from drafting and prosecuting patent applications to grant, freedom to operate opinions, infringement and validity opinions, SPCs, portfolio management, handling contracts and licenses, IP Due diligence in M&As and IP Audits.

Joeeta has written several articles and presented on IP matters at the Stevenage Bioscience Catalyst, Strategic IP Forum, mentored at an IIPLA conference, and organised webinar and conference for the Chartered Institute of Patent Attorneys. Joeeta was a former member of the IP Advisory Committee at the BioIndustry Association. In early 2022, Joeeta was elected Council Member by members of the Chartered Institute of Patent Attorneys (CIPA) to be on the CIPA Council which is the governing body of CIPA and is responsible for the strategic direction of the institute.

Prior to joining the patent profession, Joeeta has several years of research experience in Alzheimer’s disease, Diabetes, Vaccines and analytical chemistry method development, thus appreciates the technical hurdles in scientific innovation.